Thymic stromal lymphopoietin is a key mediator of breast cancer progression.
Thymic stromal lymphopoietin is a key mediator of breast cancer progression.
复制标题
DOI:
10.4049/jimmunol.1100463
复制
发表时间:
2011-05-15
期刊:
影响因子:
--
通讯作者:
Biragyn A
中科院分区:
文献类型:
--
作者:
Olkhanud PB;Rochman Y;Bodogai M;Malchinkhuu E;Wejksza K;Xu M;Gress RE;Hesdorffer C;Leonard WJ;Biragyn A
Inflammation is a double-edged sword that can promote or suppress cancer progression. Here we report that thymic stromal lymphopoietin (TSLP), an IL-7-like type 1 inflammatory cytokine that is often associated with the induction of Th2-type allergic responses in the lungs, is also expressed in human and murine cancers. Our studies with murine cancer cells indicate that TSLP plays an essential role in cancer escape, as its inactivation in cancer cells alone was sufficient to almost completely abrogate cancer progression and lung metastasis. The cancer-promoting activity of TSLP primarily required signaling through the TSLP receptor on CD4+ T cells, promoting Th2-skewed immune responses and production of immunosuppressive factors such as IL-10 and IL-13. Expression of TSLP therefore may be a useful prognostic marker and its targeting could have therapeutic potential.
登录
查看更多内容
影响因子:
11.2
作者:
Olkhanud PB;Baatar D;Bodogai M;Hakim F;Gress R;Anderson RL;Deng J;Xu M;Briest S;Biragyn A
通讯作者:
Biragyn A
DOI:
10.1084/jem.20062211
发表时间:
2007-02-19
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Allakhverdi Z;Comeau MR;Jessup HK;Yoon BR;Brewer A;Chartier S;Paquette N;Ziegler SF;Sarfati M;Delespesse G
通讯作者:
Delespesse G
DOI:
10.1084/jem.194.6.847
发表时间:
2001-09-17
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Iellem A;Mariani M;Lang R;Recalde H;Panina-Bordignon P;Sinigaglia F;D'Ambrosio D
通讯作者:
D'Ambrosio D
影响因子:
20.3
作者:
Mazzucchelli, Renata;Hixon, Julie A.;Durum, Scott K.
通讯作者:
Durum, Scott K.
DOI:
10.1111/j.1365-2613.2007.00539.x
发表时间:
2007-10-01
影响因子:
3
作者:
DuPre, Sally A.;Redelman, Doug;Hunter, Kenneth W., Jr.
通讯作者:
Hunter, Kenneth W., Jr.